Vancouver, B.C. – September 05, 2018: Pistol Bay Mining Inc. (TSX-V - PST; Frankfurt - OQS2, OTC/Pink Sheet symbol SLTFF) (“Pistol Bay” or the “Company’) is pleased to provide an update on its plans to seek opportunities outside of the resource sector and, in particular, the cannabis industry.
Charles Desjardins, President and CEO of Pistol Bay reports that the company has entered into negotiations and signed an Exclusivity Agreement to negotiate for the acquisition of the world-wide exclusive rights to market three nutraceutical products from an established private Ontario Company, that specializes in the development, manufacturing and marketing of premium phytopharmaceuticals, offering innovative solutions to complex issues of human health. The three natural health products demonstrate unique intellectual property with respect to novel ingredients, production and extraction technology. To date $5.5 million has been
spent on clinical trials to prove safety and efficacy of the foundational product, which has generated approximately USD $500 million in sales.
The foundational product is a combination of ten botanicals, wherein each contains multiple molecules that contribute to delivering adaptogen and antioxidant effects, providing noticeable improvements in physical, mental and emotional well-being.
In recent trials and testimonies this anti-stress blend has shown therapeutic benefits when combined with cannabinoids (containing minimal THC), which then formed the basis of two other products:
1. Cannabidiol (CBD) combined with the foundational adaptogen blend.
2. A full spectrum soft gel containing solely CBD.
About Adaptogens and CBD
Stress has a role in every human disease, and that the mitigation of the effects of stress is of vital importance in preserving human wellness.
Using genuine proper double-blinded placebo-controlled clinical trials it has been proven that the adaptogenic blend modulates the body’s production of cortisol (the stress hormone) without using steroidal mechanisms, but rather working through diffusing systemic physiological mechanisms.
The adaptogens contain hundreds of biologically active molecules extracted from an orchestra of plant species that have been carefully selected and prepared to function in harmony and provides tools it needs to function optimally allows it to stay healthy.
The other two products will contain cannabidiol (CBD) which is a plant-based molecule (there are hundreds of different plant-based molecules that can come from hemp and they fall mainly into the categories of terpenes, flavonoids and cannabinoids). CBD is one of over 100+ cannabinoids found in hemp.
CBD a
non-psychoactive, plant-based molecule. It is getting a lot of attention recently for its many benefits including treating pain, anxiety, inflammation, epilepsy and diabetes without the disconcerting feelings of lethargy or dysphoria. CBD works with the body’s endocannabinoid system to deliver these benefits.
The finished products containing CBD will be manufactured to comply with both US and Canadian regulatory laws, and each lot is tested to ensure THC levels are below the permitted requirements.
We are unique worldwide in that our adaptogenic blend increases the bioavailability and bioefficacy of the cannabinoids significantly.
About Pistol Bay Mining Inc. Pistol Bay Mining Inc. is a diversified Junior Canadian Mineral Exploration Company with a focus on zinc and base metal properties in North America. The company is also actively pursuing the right opportunity in the Cannabis space looking to enhance shareholders value. For additional information please visit the Company website at
www.pistolbaymininginc.com or contact Charles Desjardins at
pistolbaymining@gmail.com.
On Behalf of the Board of Directors
PISTOL BAY MINING INC. Charles Desjardins,
President and Director